Abstract:Here, we performed photo-SAR studies in a series of photoswitchable tubulin inhibiting antimitotics, and discovered that fluorescent antenna motifs permit their single-photon photoisomerisation in biological conditions at up to >600 nm; we were also able to visualise the temporal onset of their long-term photopharmacological effects, using large-field-of-view microscopy. Previously, azobenzene analogues of the tubulin polymerisation inhibitor combretastatin A4 (PSTs) had been developed to optically control microtubule dynamics in living systems, with subsecond response time and single-cell spatial precision, by reversible in situ photoswitching of their bioactivity with near-UV/visible light. First-generation PSTs were sufficiently potent and photoswitchable for use in live cells and embryos. However, the link between their seconds-scale and hours-scale bioactivity remained untested. Here, we now used tandem photoswitching/microscopy to reveal the timing of onset of their long-term bulk cytostatic effects. Since the scope for modifications to tune their photo-structure-activity-relationship or expand PST function had been unknown, we then synthesised a panel of novel PSTs exploring structural variations that tune photoresponse wavelengths and lipophilicity, identifying promising blue-shifted analogues that are better-compatible with GFP/YFP imaging. Taken together, these results can guide new design and applications for photoswitchable microtubule inhibitors. Finally, we also identified tolerated sites for linkers to attach functional cargos, and tested them with fluorescent "antennas" as reporters. Serendipitously, we found that antennas can greatly enhance long-wavelength single-photon photoisomerisation, by a hitherto un-explored mechanism. This final result will drive progress towards near-quantitative long-wavelength photoswitching of photopharmaceuticals in living systems, with minimal molecular redesign and general application scope.

Design, Synthesis, and Bioevaluation of Novel Reversibly Photoswitchable PI3K Inhibitors Based on Phenylazopyridine Derivatives toward Light-Controlled Cancer Treatment

Discovery of a Novel Photoswitchable PI3K Inhibitor Toward Optically-Controlled Anticancer Activity.

Design, Synthesis, and Biological Evaluation of a Novel Photocaged PI3K Inhibitor toward Precise Cancer Treatment

Discovery of a Photosensitizing PI3K Inhibitor for Tumor Therapy: Design, Synthesis and in Vitro Biological Evaluation.

Design, Synthesis and Biological Evaluation of Novel (Quinolinyl-3-pyridinyl)benzenesulfonamide-based Hydroxamic Acids As PI3K and HDAC Dual Targeting Inhibitors

Light-Controlled Anticancer Activity and Cellular Uptake of a Photoswitchable Cisplatin Analogue

Light Switchable Ir(III)-Based Photosensitizers: A Dual-State System for Non-Invasive, Reversible ROS Control in Tumor Therapy

Design, Synthesis, and Biological Evaluation of 4-Methyl Quinazoline Derivatives As Anticancer Agents Simultaneously Targeting Phosphoinositide 3-Kinases and Histone Deacetylases.

Arylazobenzimidazoles: Versatile Visible-Light Photoswitches with Tuneable Z-isomer Stability

Design, synthesis and bioevaluation of PI3Kα-selective inhibitors as potential colorectal cancer drugs

Design, synthesis, and biological evaluation of novel bivalent PI3K inhibitors for the potential treatment of cancer

Phenolylazoindole scaffold as facilely synthesized and bis-functional photoswitches combining controllable fluorescence and antifungal properties with theoretical methods

Design And Synthesis Of A Novel Series Of N,4-Diphenylpyrimidin-2-Amine Derivatives As Potent And Selective Pi3k Gamma Inhibitors

A photo-SAR study of photoswitchable azobenzene tubulin-inhibiting antimitotics identifying a general method for near-quantitative photocontrol

Optical Control of the GTP Affinity of K-Ras(G12C) by a Photoswitchable Inhibitor.

Azobispyrazole Family As Photoswitches Combining (Near-) Quantitative Bidirectional Isomerization and Widely Tunable Thermal Half-Lives from Hours to Years*.

Unraveling solvent and substituent effects in the photodynamics of light-dependent microtubule inhibitors for cancer phototherapy

Arylazo‐3,5‐diphenylpyrazole Derivatives: Molecular Probes Exhibiting Reversible Light‐induced Phase Transitions for Energy Storage and Direct Photolithographic Patterning

Light-Activated Azobenzene Peptide Inhibitor of the PD-1/PD-L1 Interaction

Rational Design of Bioavailable Photosensitizers for Manipulation and Imaging of Biological Systems

Conformationally Restricted Quinazolone Derivatives As PI3Kδ-selective Inhibitors: the Design, Synthesis and Biological Evaluation.